The custom antibody market is projected to grow at a CAGR of roughly 10% over the forecast period. This expansion is fueled ...
The custom antibody market is projected to grow at a CAGR of approximately 10% throughout the forecast period. This expansion is driven by increasing R&D activity, rising demand for highly specific ...
Boster Biological Technology advances biotechnology research with its cutting-edge multiplex ELISA service, delivering precision solutions in cytokine assays, custom monoclonal antibodies, and ...
The new Monash Antibody Technologies Facility (MATF) was officially opened on August 6th 2008 at a ceremony attended by a number of important dignitaries from the Australian government, academia and ...
PHILADELPHIA, Nov. 12, 2025 /PRNewswire/ -- Cell Surface Bio (CSB) announces the launch VeRSa-Select™, a custom antibody service providing scientists with unparalleled access to the highest quality ...
insights from industryDr. Zhang Lin LinTechnical SpecialistSino Biological Europe In this interview, Dr. Linlin Zhang, technical specialist for Sino Biological Europe, discusses how Sino is expanding ...
BEIJING, China, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange ...
VICTORIA, Aug. 23, 2017 /CNW/ - IMMUNOPRECISE ANTIBODIES (the "Company") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it has completed the acquisition of U-Protein Express BV ("U-Protein") ...
In a bold move that could reshape the future of biomedical research, Boster Bio is launching a Free Antibody Validation Program—giving scientists the power to test antibodies under their exact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback